Your browser doesn't support javascript.
loading
The predictive role of interim PET after the first chemotherapy cycle and sequential evaluation of response to ABVD in Hodgkin's lymphoma patients-the Polish Lymphoma Research Group (PLRG) Observational Study.
Zaucha, J M; Malkowski, B; Chauvie, S; Subocz, E; Tajer, J; Kulikowski, W; Fijolek-Warszewska, A; Biggi, A; Fallanca, F; Kobylecka, M; Dziuk, M; Woszczyk, D; Rybka, J; Kroll-Balcerzak, R; Bergesio, F; Romanowicz, A; Chamier-Cieminska, A; Kurczab, P; Giza, A; Lesniewski-Kmak, K; Zaucha, R; Swietlik, D; Wróbel, T; Knopinska-Posluszny, W; Walewski, J; Gallamini, A.
Affiliation
  • Zaucha JM; Gdynia Oncology Center, Gdynia.
  • Malkowski B; Departments of Oncological Propedeutics.
  • Chauvie S; Hematology and Transplantology, Medical University of Gdansk, Gdansk.
  • Subocz E; Nuclear Medicine Department, Oncology Center, Bydgoszcz.
  • Tajer J; Positron Emission Tomography and Molecular Imagining Department, Collegium Medicum N. Copernicus University, Bydgoszcz, Poland.
  • Kulikowski W; Medical Physics Department, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Fijolek-Warszewska A; Department of Hematology, Military Institute of Medicine, Warszawa.
  • Biggi A; Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Institute, Warszawa.
  • Fallanca F; Clinical Department of Hematology, Interior Ministry Hospital, Warmia.
  • Kobylecka M; Mazury Medical University, Olsztyn.
  • Dziuk M; Affidea Mazovian PET/CT Center, Warszawa, Poland.
  • Woszczyk D; Nuclear Medicine Department, Santa Croce e Carle Hospital, Cuneo.
  • Rybka J; Nuclear Medicine Department, San Raffaele Hospital, Milano, Italy.
  • Kroll-Balcerzak R; Nuclear Medicine Department, Warsaw Medical University, Warszawa.
  • Bergesio F; Nuclear Medicine Department, Military Institute of Medicine, Warszawa.
  • Romanowicz A; Hematology Unit, Regional Hospital, Opole.
  • Chamier-Cieminska A; Department of Hematology, Blood Neoplasms and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw.
  • Kurczab P; Department of Hematology, University Medical School, Poznan.
  • Giza A; Medical Physics Department, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Lesniewski-Kmak K; Department of Hematology, Central Clinical Hospital MSW, Warszawa.
  • Zaucha R; Department of Clinical Oncology, Oncology Center, Bydgoszcz.
  • Swietlik D; Poradnia Onkologiczna z Oddzialem Chemioterapii Dziennej NZOZ Mrukmed, Rzeszów.
  • Wróbel T; Department of Hematology, Jagiellonian University Medical College, Krakow.
  • Knopinska-Posluszny W; Gdynia Oncology Center, Gdynia.
  • Walewski J; Departments of Oncological Propedeutics.
  • Gallamini A; Hematology and Transplantology, Medical University of Gdansk, Gdansk.
Ann Oncol ; 28(12): 3051-3057, 2017 Dec 01.
Article in En | MEDLINE | ID: mdl-28950332
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Positron-Emission Tomography Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease / Antineoplastic Combined Chemotherapy Protocols / Positron-Emission Tomography Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2017 Type: Article